“In Silico Study of Secondary Metabolite in Asiatic Pennywort (Centella asiatica) as a Drug Compound for Blood Cancer  (Acute Lymphoblastic Leukemia (ALL)) Targeting JAK-2 Receptor”, ijcs, vol. 14, no. 1, pp. 18–27, May 2025, doi: 10.15294/ijcs.v14i1.8946.